• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    Why HyreCar Is Trading Higher By 60%, Here Are 63 Stocks Moving In Tuesday's Mid-Day Session

    9/6/22 1:36:41 PM ET
    $ADT
    $ADTN
    $AKU
    $ALNA
    Diversified Commercial Services
    Consumer Discretionary
    Telecommunications Equipment
    Utilities
    Get the next $ADT alert in real time by email

    Gainers

    • HyreCar Inc. (NASDAQ:HYRE) jumped 60% to $1.2680 after the company announced it has received a $100 million revolving line of credit from a premier global investment bank and Medalist Partners.
    • ChannelAdvisor Corporation (NYSE:ECOM) shares climbed 54.9% to $22.77 after the company announced it will be acquired by CommerceHub for $23.10 per share
    • IVERIC bio, Inc. (NASDAQ:ISEE) gained 41.4% to $13.35 after the company announced positive data from the second Phase 3 trial of Zimura (avacincaptad pegol) for geographic atrophy (GA).
    • Nutex Health, Inc. (NASDAQ:NUTX) rose 39% to $3.33. Nutex Health recently reported Q2 earnings results.
    • Shuttle Pharmaceuticals Holdings, Inc. (NASDAQ:SHPH) rose 37.4% to $20.47 amid post-IPO volatility.
    • First Wave BioPharma, Inc. (NASDAQ:FWBI) shares climbed 34.1% to $4.2650 after gaining 7% on Friday.
    • Spero Therapeutics, Inc. (NASDAQ:SPRO) surged 30% to $0.9472. Spero Therapeutics received minutes from a recent Type A meeting with the FDA, discussing steps required to resubmit the marketing application for tebipenem HBr for complicated urinary tract infection (cUTI).
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) jumped 20% to $1.11 after climbing over 23% on Friday.
    • Kaspien Holdings Inc. (NASDAQ:KSPN) rose 18.7% to $2.92.
    • CytomX Therapeutics, Inc. (NASDAQ:CTMX) gained 18.5% to $1.73. CytomX Therapeutics, last month, posted a Q2 loss of $0.37 per share.
    • SelectQuote, Inc. (NYSE:SLQT) jumped 17.3% to $1.1150. SelectQuote recently said Q4 sales results were lower year-over-year and issued FY23 sales guidance below analyst estimates.
    • Pear Therapeutics, Inc. (NASDAQ:PEAR) rose 16% to $2.47. Pear Therapeutics, last month, posted Q2 EPS of $0.04.
    • LifeStance Health Group, Inc. (NASDAQ:LFST) gained 16% to $7.93.
    • Apexigen, Inc. (NASDAQ:APGN) gained 15.9% to $6.06.
    • Regulus Therapeutics Inc. (NASDAQ:RGLS) jumped 15.4% to $1.6383. Regulus Therapeutics, last month, posted a Q2 loss of $0.50 per share.
    • American Virtual Cloud Technologies, Inc. (NASDAQ:AVCT) gained 15% to $0.2428. American Virtual Cloud Technologies recently announced an equity distribution agreement to offer and sell up to $14.7 million shares of common stock.
    • Akumin Inc. (NASDAQ:AKU) gained 13.4% to $1.35. Akumin recently received notification letter from the Nasdaq confirming that company had regained compliance with minimum bid price requirement.
    • Dakota Gold Corp. (NYSE:DC) jumped 12.9% to $3.49.
    • ADT Inc. (NYSE:ADT) gained 12.4% to $8.10 after the company announced it has secured investments totaling $1.5 billion from State Farm and Google.
    • SES AI Corporation (NYSE:SES) jumped 12% to $5.24.
    • InMed Pharmaceuticals Inc. (NASDAQ:INM) gained 10.7% to $0.3544 after gaining around 5% on Friday.
    • TScan Therapeutics, Inc. (NASDAQ:TCRX) rose 10.4% to $3.61.
    • Organovo Holdings, Inc. (NASDAQ:ONVO) gained 10% to $2.54.
    • Nordic American Tankers Limited (NYSE:NAT) rose 9.8% to $2.8550. Jefferies upgraded Nordic American Tankers from Hold to Buy and raised the price target from $3 to $4.
    • Zeta Global Holdings Corp. (NYSE:ZETA) jumped 9.4% to $6.99.
    • Outfront Media Inc. (NYSE:OUT) rose 7.7% to $18.60 after it was announced the company is set to join the S&P SmallCap 600.
    • Belite Bio, Inc (NASDAQ:BLTE) gained 7.2% to $37.40.


    Don’t forget to check out our premarket coverage here .

    Losers

    • ProKidney Corp. (NASDAQ:PROK) shares tumbled 31.3% to $7.01. ProKidney recently named Glenn Schulman, PharmD, MPH, as Senior Vice President of Investor Relations.
    • Allena Pharmaceuticals, Inc. (NASDAQ:ALNA) dropped 27.4% to $0.0760 after the company announced it has filed for bankruptcy.
    • Creatd, Inc. (NASDAQ:CRTD) shares fell 26.4% to $0.2766 after dipping 31% on Friday. Creatd received delist decision and received 15 days to file appeal.
    • ZeroFox Holdings, Inc. (NASDAQ:ZFOX) dropped 26.2% to $3.8477.
    • Eiger BioPharmaceuticals, Inc. (NASDAQ:EIGR) shares fell 25.8% to $6.34 after the company provided an update on the status of its planned request for EUA of peginterferon lambda, saying "the agency has indicated that it is not yet able to determine whether the criteria for the submission of an application and issuance of an EUA are likely to be met."
    • Presidio Property Trust, Inc. (NASDAQ:SQFT) fell 25.3% to $2.35. Presidio Property Trust declared Q3 dividend and adopted variable dividend policy.
    • Hempacco Co., Inc. (NASDAQ:HPCO) dipped 23.3% to $4.3250.
    • POINT Biopharma Global Inc. (NASDAQ:PNT) fell 20.9% to $8.10.
    • bioAffinity Technologies, Inc. (NASDAQ:BIAF) fell 20.8% to $5.58 after dropping 15% on Friday. The company, last week, priced its IPO at $6.125 per unit.
    • Digital World Acquisition Corp (NASDAQ:DWAC) shares fell 19.2% to $20.20. Shareholders have rejected the special purpose acquisition company’s proposal to extend by a year the deadline for its merger with former President Donald Trump’s Trump Media & Technology, which operates the Truth Social platform, Reuters reported.
    • Rigetti Computing, Inc. (NASDAQ:RGTI) dropped 19% to $2.9488.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) declined 18.3% to $2.4650 following downbeat quarterly sales.
    • Addentax Group Corp. (NASDAQ:ATXG) shares fell 18% to $7.78 following the company's uplisting and IPO.
    • Sera Prognostics, Inc. (NASDAQ:SERA) fell 17% to $1.6450. Sera Prognostics, last month, posted a Q2 loss of $0.37 per share.
    • ShiftPixy, Inc. (NASDAQ:PIXY) dropped 16.9% to $11.30.
    • Nuwellis, Inc. (NASDAQ:NUWE) dipped 16.3% to $1.03.
    • Tupperware Brands Corporation (NYSE:TUP) declined 16.3% to $9.22.
    • Glatfelter Corporation (NYSE:GLT) fell 15.8% to $4.1550. Glatfelter recently named Mr. Thomas Fahnemann as President and Chief Executive Officer.
    • CalAmp Corp. (NASDAQ:CAMP) dropped 15.5% to $4.6050.
    • PaxMedica, Inc. (NASDAQ:PXMD) fell 15.2% to $4.3863 following the company's recent IPO.
    • Bed Bath & Beyond Inc. (NASDAQ:BBBY) fell 14.7% to $7.36 following the passing of CFO Gustavo Arnal. Raymond James recently downgraded the stock form Market Perform to Underperform.
    • eHealth, Inc. (NASDAQ:EHTH) dropped 14.3% to $4.8450.
    • Cheetah Mobile Inc. (NYSE:CMCM) fell 14.3% to $3.17.
    • ASAP, Inc. (NASDAQ:WTRH) fell 14.2% to $0.1980.
    • Mind Medicine (MindMed) Inc. (NASDAQ:MNMD) dropped 14% to $9.95.
    • Wheeler Real Estate Investment Trust, Inc. (NASDAQ:WHLR) fell 13.2% to $2.30 after climbing around 27% on Friday.
    • Burcon NutraScience Corporation (NASDAQ:BRCN) fell 12.7% to $0.4542 as the company reported delisting from Nasdaq Capital Market on or about September 12. The company also announced auditor resignation and postponement of annual meeting of shareholders.
    • Tango Therapeutics, Inc. (NASDAQ:TNGX) fell 12.6% to $3.74.
    • Getty Images Holdings, Inc. (NYSE:GETY) dropped 12.2% to $13.05.
    • Kuke Music Holding Limited (NYSE:KUKE) fell 12.1% to $0.7210 after dipping 27% on Friday.
    • Jianzhi Education Technology Group Company Limited (NASDAQ:JZ) fell 11.5% to $4.71.
    • MoonLake Immunotherapeutics (NASDAQ:MLTX) dipped 11.1% to $7.66.
    • Hillenbrand, Inc. (NYSE:HI) dropped 8.5% to $37.12. The company, last month, posted upbeat quarterly results.
    • ADTRAN Holdings, Inc. (NASDAQ:ADTN) fell 8.4% to $20.73.
    • HIVE Blockchain Technologies Ltd. (NASDAQ:HIVE) fell 7.3% to $4.44. HIVE reported its August 2022 production figures and mining capacity.
    • GameStop Corp. (NYSE:GME) fell 7.2 to $25.40.
    Get the next $ADT alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ADT
    $ADTN
    $AKU
    $ALNA

    CompanyDatePrice TargetRatingAnalyst
    MoonLake Immunotherapeutics
    $MLTX
    3/19/2026$40.00Neutral → Buy
    Rothschild & Co Redburn
    CytomX Therapeutics Inc.
    $CTMX
    3/16/2026$12.00Neutral → Overweight
    Analyst
    ADT Inc.
    $ADT
    3/6/2026$7.00Equal Weight → Underweight
    Barclays
    eHealth Inc.
    $EHTH
    2/26/2026$2.00Buy → Hold
    Craig Hallum
    Dakota Gold Corp.
    $DC
    2/24/2026$10.00Sector Outperform
    Scotiabank
    Tango Therapeutics Inc.
    $TNGX
    2/23/2026$19.00Outperform
    Mizuho
    Rigetti Computing Inc.
    $RGTI
    2/12/2026Buy → Hold
    TD Cowen
    Kingsoft Cloud Holdings Limited
    $KC
    2/11/2026$15.60Neutral → Buy
    Goldman
    More analyst ratings

    $ADT
    $ADTN
    $AKU
    $ALNA
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for IZERVAY issued to IVERIC BIO, INC.

    Submission status for IVERIC BIO, INC.'s drug IZERVAY (ORIG-1) with active ingredient AVACINCAPTAD PEGOL has changed to 'Approval' on 08/04/2023. Application Category: NDA, Application Number: 217225, Application Classification: Type 1 - New Molecular Entity

    8/9/23 8:37:19 AM ET
    $ISEE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ADT
    $ADTN
    $AKU
    $ALNA
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    MoonLake Immunotherapeutics upgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn upgraded MoonLake Immunotherapeutics from Neutral to Buy and set a new price target of $40.00

    3/19/26 8:23:34 AM ET
    $MLTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    CytomX Therapeutics upgraded by Analyst with a new price target

    Analyst upgraded CytomX Therapeutics from Neutral to Overweight and set a new price target of $12.00

    3/16/26 11:34:14 AM ET
    $CTMX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    ADT downgraded by Barclays with a new price target

    Barclays downgraded ADT from Equal Weight to Underweight and set a new price target of $7.00

    3/6/26 8:24:43 AM ET
    $ADT
    Diversified Commercial Services
    Consumer Discretionary

    $ADT
    $ADTN
    $AKU
    $ALNA
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    The Patent Cliff is Coming, Driving Smart Money Towards Precision Oncology

    VANCOUVER, British Columbia, March 19, 2026 (GLOBE NEWSWIRE) -- Equity-Insider.com News Commentary — Big money is moving back into biotech. Institutional investors have been writing some of the largest checks in years, with major financing rounds already closing in the first months of 2026[1], a sign that capital is rotating toward clinical-stage companies with validated science. That capital is not spreading evenly: it is concentrating on precision medicine, where the global oncology precision medicine market is projected to reach $303 billion by 2035[2], growing at approximately 9% annually as targeted cancer treatments move from promising idea to standard care. The five companies in thi

    3/19/26 11:00:00 AM ET
    $ATOS
    $ONCY
    $SNSE
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Combination Therapies Reshape Oncology: A $748B Market Shifts Standard of Care

    Issued on behalf of Oncolytics Biotech Inc.VANCOUVER, BC, March 19, 2026 /CNW/ -- USANewsGroup.com News Commentary -- The global oncology market is valued at $279.98 billion in 2026 and is on track to reach $748.17 billion by 2035[1], a structural realignment driven by the shift from single-agent treatments toward synergistic combination platforms and next-gen cell therapies. The immuno-oncology segment alone is projected to expand from $65.22 billion in 2025 to $170.19 billion by 2032[2], as a wave of combination therapy approvals converts tumors once resistant to immunotherapy into viable targets. Institutions are positioning for this shift through companies like Oncolytics Biotech (NASDAQ

    3/19/26 10:00:00 AM ET
    $DAWN
    $ENGN
    $GILD
    Biotechnology: Pharmaceutical Preparations
    Health Care
    Biotechnology: Biological Products (No Diagnostic Substances)

    Cheetah Mobile To Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 24, 2026

    BEIJING, March 19, 2026 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE: CMCM), a China-based IT company with a commitment to AI innovation, today announced that it will report its financial results for the fourth quarter and fiscal year 2025 before the U.S. market opens on Tuesday, March 24, 2026. The earnings release will be available on the Company's investor relations website at http://ir.cmcm.com. Cheetah Mobile's management will hold an earnings conference call at 7:00 AM on Tuesday, March 24, 2026, U.S. Eastern Time (7:00 PM on Tuesday, March 24, 2026, Beijing Time/Hong Kong Time).Participants may access the call by dialing the following numbers:Main Line

    3/19/26 9:00:00 AM ET
    $CMCM
    Computer Software: Prepackaged Software
    Technology

    $ADT
    $ADTN
    $AKU
    $ALNA
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Chief Legal Officer-Healthcare Montgomery Pamela W. bought $7,021 worth of shares (79 units at $88.87), increasing direct ownership by 3% to 2,758 units (SEC Form 4)

    4 - Nutex Health Inc. (0001479681) (Issuer)

    3/16/26 3:02:43 PM ET
    $NUTX
    Real Estate

    Director Tabacco Joseph J Jr bought $102,200 worth of shares (20,000 units at $5.11) (SEC Form 4)

    4 - BED BATH & BEYOND, INC. (0001130713) (Issuer)

    3/12/26 8:32:43 PM ET
    $BBBY
    Catalog/Specialty Distribution
    Consumer Discretionary

    EVP, Chief People & Admin. Off Scott David A. bought $49,056 worth of shares (7,300 units at $6.72) (SEC Form 4)

    4 - ADT Inc. (0001703056) (Issuer)

    3/9/26 5:28:50 PM ET
    $ADT
    Diversified Commercial Services
    Consumer Discretionary

    $ADT
    $ADTN
    $AKU
    $ALNA
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    SEC Form 3 filed by new insider Fu Sheng

    3 - Cheetah Mobile Inc. (0001597835) (Issuer)

    3/18/26 9:56:17 PM ET
    $CMCM
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Li Yi

    3 - Kingsoft Cloud Holdings Ltd (0001795589) (Issuer)

    3/18/26 5:52:33 PM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    SEC Form 3 filed by new insider Tian Kaiyan

    3 - Kingsoft Cloud Holdings Ltd (0001795589) (Issuer)

    3/18/26 5:52:29 PM ET
    $KC
    Computer Software: Prepackaged Software
    Technology

    $ADT
    $ADTN
    $AKU
    $ALNA
    SEC Filings

    View All

    Getty Images Holdings Inc. filed SEC Form 8-K: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing, Regulation FD Disclosure, Financial Statements and Exhibits

    8-K - Getty Images Holdings, Inc. (0001898496) (Filer)

    3/19/26 9:04:41 AM ET
    $GETY
    Real Estate

    SEC Form 424B5 filed by Sera Prognostics Inc.

    424B5 - SERA PROGNOSTICS, INC. (0001534969) (Filer)

    3/18/26 4:48:39 PM ET
    $SERA
    Medical Specialities
    Health Care

    SEC Form S-8 filed by Sera Prognostics Inc.

    S-8 - SERA PROGNOSTICS, INC. (0001534969) (Filer)

    3/18/26 4:09:59 PM ET
    $SERA
    Medical Specialities
    Health Care

    $ADT
    $ADTN
    $AKU
    $ALNA
    Leadership Updates

    Live Leadership Updates

    View All

    Nuwellis Appoints Dr. Stuart L. Goldstein as Director of Clinical Strategy to Advance Pediatric and Cardiorenal Strategy

    MINNEAPOLIS, March 05, 2026 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (NASDAQ:NUWE), a medical technology company committed to delivering solutions for patients with cardiorenal conditions, today announced the appointment of Stuart L. Goldstein, MD, FASN as Director of Clinical Strategy. Dr. Goldstein is internationally recognized as a pioneer in pediatric nephrology and critical care medicine. He serves as Director of the Center for Acute Care Nephrology, holds the Clark D. West Endowed Chair in Pediatric Nephrology at Cincinnati Children's Hospital Medical Center and is Professor of Pediatrics at the University of Cincinnati College of Medicine. His work has helped define the modern understand

    3/5/26 8:00:00 AM ET
    $NUWE
    Biotechnology: Electromedical & Electrotherapeutic Apparatus
    Health Care

    Tango Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights

    Initial Phase 1/2 trial data of vopimetostat in combination with Revolution Medicines' RAS(ON) inhibitors in MTAP-deleted pancreatic cancer in 2026 with continued robust patient enrollment New clinical supply agreement with Erasca, plus ongoing Revolution Medicines collaboration, supports potential of vopimetostat as the preferred PRMT5 inhibitor for combination with RAS targeted therapies in oncology Cash position of $343 million as of December 31, 2025, with runway into 2028 beyond anticipated key data inflection points BOSTON, March 05, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ:TNGX), a clinical-stage biotechnology company committed to discovering and delivering the n

    3/5/26 7:00:00 AM ET
    $TNGX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Dakota Gold Announces Appointment of Brian G. Iverson to Board of Directors

    Lead, South Dakota--(Newsfile Corp. - February 27, 2026) - Dakota Gold Corp. (NYSE:DC) ("Dakota Gold" or the "Company") is pleased to announce the appointment of Brian G. Iverson to its Board of Directors ("Board"), effective immediately. Mr. Iverson brings more than three decades of strategic leadership experience across legal, financial, regulatory, and corporate governance functions for South Dakotan companies. Mr. Iverson's local and professional experience compliment the Company's Board as Dakota Gold advances its exploration and development initiatives in South Dakota's historic Homestake District.Mr. Iverson currently serves as General Counsel and Senior Vice President Regulatory and

    2/27/26 6:30:00 AM ET
    $BKH
    $DC
    Electric Utilities: Central
    Utilities
    Metal Mining
    Basic Materials

    $ADT
    $ADTN
    $AKU
    $ALNA
    Financials

    Live finance-specific insights

    View All

    Cheetah Mobile To Report Fourth Quarter and Fiscal Year 2025 Financial Results on March 24, 2026

    BEIJING, March 19, 2026 /PRNewswire/ -- Cheetah Mobile Inc. ("Cheetah Mobile" or the "Company") (NYSE: CMCM), a China-based IT company with a commitment to AI innovation, today announced that it will report its financial results for the fourth quarter and fiscal year 2025 before the U.S. market opens on Tuesday, March 24, 2026. The earnings release will be available on the Company's investor relations website at http://ir.cmcm.com. Cheetah Mobile's management will hold an earnings conference call at 7:00 AM on Tuesday, March 24, 2026, U.S. Eastern Time (7:00 PM on Tuesday, March 24, 2026, Beijing Time/Hong Kong Time).Participants may access the call by dialing the following numbers:Main Line

    3/19/26 9:00:00 AM ET
    $CMCM
    Computer Software: Prepackaged Software
    Technology

    Spero Therapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Provide Business Update on March 26, 2026

    CAMBRIDGE, Mass., March 18, 2026 (GLOBE NEWSWIRE) -- Spero Therapeutics, Inc. (NASDAQ:SPRO), a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare diseases and diseases with high unmet need, today announced that it will report its financial results for the fourth quarter and full year ended December 31, 2025, and provide a business update on Thursday, March 26, 2026, after market close. The Company does not intend to host a conference call. About Spero TherapeuticsSpero Therapeutics, headquartered in Cambridge, Massachusetts, is a clinical-stage biopharmaceutical company focused on identifying and developing novel treatments for rare di

    3/18/26 4:05:00 PM ET
    $SPRO
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Getty Images Reports Fourth Quarter and Full Year 2025 Results

    Delivered full-year revenue of $981.3 million, well above upper end of guidance and the highest reported revenue in the Company's 30-year historyFull-year revenue growth of 4.5%, currency neutral growth of 3.8%Q4 revenue growth of 14.1%, currency neutral growth of 12.7%Shutterstock merger has obtained regulatory clearance without conditions in all jurisdictions except UK, where the CMA's final report is due by June 14 NEW YORK, March 16, 2026 (GLOBE NEWSWIRE) -- Getty Images Holdings, Inc. ("Getty Images" or the "Company") (NYSE:GETY), a preeminent global visual content creator and marketplace, today reported financial results for the fourth quarter and full year ended December 31, 2025.

    3/16/26 4:07:00 PM ET
    $GETY
    Real Estate

    $ADT
    $ADTN
    $AKU
    $ALNA
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13D/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/9/24 5:54:19 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    Amendment: SEC Form SC 13G/A filed by Wheeler Real Estate Investment Trust Inc.

    SC 13G/A - Wheeler Real Estate Investment Trust, Inc. (0001527541) (Subject)

    12/5/24 5:28:41 PM ET
    $WHLR
    Real Estate Investment Trusts
    Real Estate

    SEC Form SC 13G filed by Rigetti Computing Inc.

    SC 13G - Rigetti Computing, Inc. (0001838359) (Subject)

    12/5/24 10:15:39 AM ET
    $RGTI
    EDP Services
    Technology